Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: Comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI | Zendy

ChenTe Chou | Zendy; RanChou Chen | Zendy; Wei-Tsung Chen | Zendy; JiunnMing Lii | Zendy

Open Access

Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: Comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI

Author(s) -

ChenTe Chou,

RanChou Chen,

Wei-Tsung Chen,

JiunnMing Lii

Publication year - 2011

Publication title -

journal of the chinese medical association

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.535

H-Index - 42

eISSN - 1728-7731

pISSN - 1726-4901

DOI - 10.1016/j.jcma.2011.01.013

Subject(s) - medicine , magnetic resonance imaging , gadolinium , t2 weighted , gadolinium dtpa , nuclear medicine , radiology , nuclear magnetic resonance , materials science , metallurgy , physics

T1-weighted (T1W) hyperintense nodules against a background of cirrhosis are diagnostically challenging in daily practice. All regenerative nodules, dysplastic nodules and hepatocellular carcinoma (HCC) might present hyperintense on T1W imaging (T1WI), so T1W hyperintense nodules cannot be definitively characterized as dysplastic nodules or HCC before biopsy, resection or transplantation. The purpose of our study was to evaluate Ferucarbotran-enhanced Magnetic Resonance Imaging (MRI) with accumulation-phase fat suppression T1-weighted imaging (FS-T1WI) in comparison with gadolinium-enhanced MRI for characterization of hyperintense nodules on unenhanced T1WI within cirrhotic liver.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research